Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe MushroomsField Trip Health Ltd. Continues Expansion With Psychedelic-Enhanced Therapy Center in ChicagoCSE Bulletin: New Listing – Psyched Wellness Ltd. (PSYC)HAVN Life Sciences Has Been One Of The Best Performing Stocks In The Psychedelics Sector Over The Past MonthHavn Life Sciences Signs Agreement to Supply Psychedelic Compounds for use in Research and Development to Revive TherapeMindset Pharma Commences In Vivo Program for Its Proprietary Next Generation Psychedelic Drug Candidates and Provides CoCYBIN and Clarmin Announce Closing of CDN$45 Million Oversubscribed Private Placement and Provide Update on RTOWake Network Is Laser Focused On Advancing Fungi-Based Medicine Through Cutting Edge Technology and Clinical ResearchMydecine Innovations Group subsidiary NeuroPharm Engages FreeMind Group to Access Non-Dilutive Global Funding OpportunitCybin Corp’s Clinical Trials In Jamaica Are Setting The Company Up For A Quicker Route To Market Than Their PeersMindMed Announces $25 Million Bought Deal Public Offering3 Psychedelic Stocks With The Highest Chance Of Successfully Bringing A Psychedelic Therapy To MarketMydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with PsilocybinCompass Pathways and Cybin Corp Are Two Of The Most Compelling Enterprises We Have Seen In The Psychedelics Sector Thus MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies andHavn Life Sciences Announces Appointments of Vic Neufeld as Chairman and Rick Brar as Vice Chairman of the Board of DireHavn Life joins UK Psychedelics Working Group with Leading International ScientistsMind Cure Is Deploying A “5 Sphere” Strategy To Plant Their Flag In The Psychedelics SectorCEO Spotlight: David Kerbel of Rritual MushroomsNuminus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory

Technical420 Site Search

Returned 4 result(s).

Cybin Corp Announces Doug Drysdale as Chief Executive Officer

Cybin Corp. (the “Company or “Cybin”), a life sciences company advancing psychedelic pharmaceuticals, is pleased to announce that Mr. Doug Drysdale has been appointed as Chief Executive Officer. Doug has more than 30 years of experience in the health care sector. As a skillful corporate director, in early 2014, Doug…

International Cannabrands CEO Publishes March 2020 Status Letter to Shareholders

International Cannabrands Inc. (CSE: INCB) CEO Steve Gormley publishes an open status letter to Shareholders. Dear Shareholders, 2020 has already been a pivotal year for INCB's expanding footprint. As we continue to move forward, I wanted to take this moment to highlight some finer points of recent announcements as well…

Namaste Board Launches Strategic Review Process; Announces Termination of CEO Sean Dollinger and Commences Legal Action

Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) announced today that, following a recent expression of interest in the Company, the Board of Directors of the Company (the "Board") has launched a strategic review process to consider all value-maximizing alternatives.Namaste also announced that following an…

X-SPRAYS Appoints John Knapp as Chief Executive Officer

CNRP Mining Inc. (CSE:CND) (OTCQB:CRPGF), is pleased to announce that X-SPRAYS, subject to regulatory approval, has appointed John Knapp as the new Chief Executive Officer effective immediately.Mr. Knapp brings over 8 years of experience in the cannabis industry to X-SPRAYS. A pioneer in the legal cannabis industry, John Knapp is…

Search Again

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link